Brett A. Wall - 28 May 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Neuroscience
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
28 May 2021
Transactions value $
-$669,687
Form type
4
Filing time
02 Jun 2021, 18:00:30 UTC
Next filing
22 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $578K +12.3K +64.69% $47.00 31.3K 28 May 2021 Direct F1, F2
transaction MDT Ordinary Shares Tax liability -$931K -7.36K -23.49% $126.59 24K 28 May 2021 Direct F1
transaction MDT Ordinary Shares Sale -$317K -2.47K -10.32% $128.07 21.5K 01 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -12.3K -100% $0.00* 0 28 May 2021 Ordinary Shares 12.3K $47.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This balance increased by 300 shares due to exempt transactions such as dividend reinvestment.
F3 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.